Glucotrack (GCTK) EPS (Weighted Average and Diluted) (2012 - 2025)
Glucotrack (GCTK) recorded quarterly EPS (Weighted Average and Diluted) of $1.13 in Q4 2025, down 75.65% on a QoQ basis from $4.64 in Q3 2025, and down 99.91% year-over-year from $1238.0 in Q4 2024.
Glucotrack (GCTK) EPS (Weighted Average and Diluted) (2012 - 2025) Analysis & Trends
Glucotrack has disclosed EPS (Weighted Average and Diluted) across 13 years of filings, most recently posting $1.13 for Q4 2025.
- Quarterly EPS (Weighted Average and Diluted) fell 99.91% year-over-year to $1.13 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $14.72 (down 99.55% YoY) and the FY2025 annual result came in at $31.22, down 99.24% from the prior year.
- EPS (Weighted Average and Diluted) declined to $1.13 in Q4 2025, from $4.64 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at $1238.0 in Q4 2024 and troughed at -$11.73 in Q1 2024.
- A 5-year average of $186.27 and a median of $0.35 in 2021 frame the typical range for EPS (Weighted Average and Diluted).
- Biggest YoY gain for EPS (Weighted Average and Diluted) was 364344.44% in 2024; the steepest drop was 14562.5% in 2024.
- Tracing GCTK's EPS (Weighted Average and Diluted) over 5 years: stood at $0.43 in 2021, then grew by 13.95% to $0.49 in 2022, then jumped by 7157.14% to $35.56 in 2023, then jumped by 3381.44% to $1238.0 in 2024, then slumped by 99.91% to $1.13 in 2025.
- Business Quant data shows GCTK's EPS (Weighted Average and Diluted) at $1.13 in Q4 2025, $4.64 in Q3 2025, and $9.62 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 2.28 |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -1.11 |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 0.16 |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 2.74 |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 1.92 |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 0.07 |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -0.40 |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 1.57 |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -0.03 |
| 10 | Glucotrack | 4.26 | -7.38 Mn | - | 1.13 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.13 |
| Sep 30, 2025 | 4.64 |
| Jun 30, 2025 | 9.62 |
| Mar 31, 2025 | -0.67 |
| Dec 31, 2024 | 1,238.00 |
| Sep 30, 2024 | 1,092.00 |
| Jun 30, 2024 | 984.00 |
| Mar 31, 2024 | -11.73 |
| Dec 31, 2023 | 35.56 |
| Sep 30, 2023 | -0.49 |
| Jun 30, 2023 | 0.27 |
| Mar 31, 2023 | -0.08 |
| Dec 31, 2022 | 0.49 |
| Sep 30, 2022 | -0.06 |
| Jun 30, 2022 | -0.07 |
| Dec 31, 2021 | 0.43 |
| Sep 30, 2021 | -0.05 |
| Jun 30, 2021 | -0.06 |
| Dec 31, 2020 | 0.31 |
| Sep 30, 2020 | -0.03 |